These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27511813)

  • 1. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
    Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
    Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome.
    Guervilly C; Bisbal M; Forel JM; Mechati M; Lehingue S; Bourenne J; Perrin G; Rambaud R; Adda M; Hraiech S; Marchi E; Roch A; Gainnier M; Papazian L
    Intensive Care Med; 2017 Mar; 43(3):408-418. PubMed ID: 28013329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Fixed Dosing vs Train of Four Titration of Cisatracurium in COVID-19 ARDS Patients.
    Banerjee O; Elefritz JL; Doepker BA; Atyia SA; Brummel NE; Smith RM; Handley D; Cape KM
    J Pharm Pract; 2024 Oct; 37(5):1082-1090. PubMed ID: 38087423
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.
    Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K
    J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
    Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M
    Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 8. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular Blockade Monitoring in Acute Respiratory Distress Syndrome: Randomized Controlled Trial of Clinical Assessment Alone or With Peripheral Nerve Stimulation.
    Rezaiguia-Delclaux S; Laverdure F; Genty T; Imbert A; Pilorge C; Amaru P; Sarfati C; Stéphan F
    Anesth Analg; 2021 Apr; 132(4):1051-1059. PubMed ID: 33002927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blockers and ARDS.
    Gusmão D
    N Engl J Med; 2010 Dec; 363(26):2562-3; author reply 2563-4. PubMed ID: 21175321
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended neuromuscular blockade in acute respiratory distress syndrome does not increase mortality.
    Barmparas G; Dhillon NK; Tatum JM; Patel K; Thomsen GM; Mason R; Margulies DR; Ley EJ
    J Surg Res; 2018 Nov; 231():434-440. PubMed ID: 30278965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
    Riley K; Yampolsky N; Hakma Z; Moussouttas M
    Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of deep or moderate neuromuscular blockade for thoracoscopic lobectomy: a randomized controlled trial.
    Zhang XF; Li DY; Wu JX; Jiang QL; Zhu HW; Xu MY
    BMC Anesthesiol; 2018 Dec; 18(1):195. PubMed ID: 30577757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisatracurium dosing in a patient with hyperthermia.
    Lim J; Cox J; Nguyen T; Arya R
    Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus injection.
    Dong YJ; Li X
    Contemp Clin Trials; 2012 May; 33(3):482-5. PubMed ID: 22269820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.